These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25984851)

  • 1. It's Not All About Breast Density: Risk Matters.
    Dolan NC; Goel MS
    Ann Intern Med; 2015 May; 162(10):729-30. PubMed ID: 25984851
    [No Abstract]   [Full Text] [Related]  

  • 2. Not all women with dense breasts need further imaging after normal mammogram, study shows.
    Mayor S
    BMJ; 2015 May; 350():h2690. PubMed ID: 25991006
    [No Abstract]   [Full Text] [Related]  

  • 3. Summaries for Patients. Identifying women with dense breasts at high risk for interval cancer.
    Ann Intern Med; 2015 May; 162(10):. PubMed ID: 25984867
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying women with dense breasts at high risk for interval cancer: a cohort study.
    Kerlikowske K; Zhu W; Tosteson AN; Sprague BL; Tice JA; Lehman CD; Miglioretti DL;
    Ann Intern Med; 2015 May; 162(10):673-81. PubMed ID: 25984843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for Patients. Screening for Breast Cancer: Recommendations From the U.S. Preventive Services Task Force.
    Ann Intern Med; 2016 Feb; 164(4):. PubMed ID: 26756910
    [No Abstract]   [Full Text] [Related]  

  • 6. Mammography in younger women: the dilemma of diminishing returns.
    Calonge N
    J Natl Cancer Inst; 2010 May; 102(10):668-9. PubMed ID: 20439837
    [No Abstract]   [Full Text] [Related]  

  • 7. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Assessment in Population-Based Breast Cancer Screening.
    Eriksson M; Conant EF; Kontos D; Hall P
    J Clin Oncol; 2022 Jul; 40(20):2279-2280. PubMed ID: 35452252
    [No Abstract]   [Full Text] [Related]  

  • 9. Do I have breast cancer?
    Fountain M
    Nurs Manage; 2000 Apr; 31(4):34-7. PubMed ID: 15127638
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of health benefits and cost-effectiveness of mammography for breast cancer.
    Keen JD
    Ann Intern Med; 2011 Oct; 155(8):566; author reply 566-7. PubMed ID: 22007057
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer Recognition and Screening for Common Breast Disorders and Malignancy.
    Bohon C
    Obstet Gynecol Clin North Am; 2017 Jun; 44(2):257-270. PubMed ID: 28499535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluating the benefits of mammographic breast cancer screening].
    Kullmann T; Misset JL
    Orv Hetil; 2010 Aug; 151(35):1409-14. PubMed ID: 20719714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).
    Gabrielson M; Eriksson M; Hammarström M; Borgquist S; Leifland K; Czene K; Hall P
    Int J Epidemiol; 2017 Dec; 46(6):1740-1741g. PubMed ID: 28180256
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
    Lester J
    Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Efficacy of breast cancer screening in the community according to risk level.
    Duffy SW; Smith RA; Tabar L
    J Natl Cancer Inst; 2005 Nov; 97(22):1703; author reply 1703-4. PubMed ID: 16288125
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.
    Sala M; Comas M; Macià F; Martinez J; Casamitjana M; Castells X
    Radiology; 2009 Jul; 252(1):31-9. PubMed ID: 19420316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACP Journal Club. Review: In women 50 to 69 y of age at average risk, mammography screening reduces breast cancer mortality.
    Krager SC; Prochazka AV
    Ann Intern Med; 2016 Apr; 164(8):JC38. PubMed ID: 27089086
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening mammography in women less than age 50 years.
    Kerlikowske K
    Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards Prevention of Breast Cancer: What Are the Clinical Challenges?
    Borgquist S; Hall P; Lipkus I; Garber JE
    Cancer Prev Res (Phila); 2018 May; 11(5):255-264. PubMed ID: 29661853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.